R&D Expenses. Notwithstanding the provisions of Section 2.3 of the Agreement (as amended pursuant to the Third and Fourth Letter Amendments), DuPont and Genencor agree that as of 1st January, 2002 and for the remaining term of the Agreement as extended by this Fifth Letter Amendment, DuPont shall pay Genencor for R&D expenses for work on the R&D Program at the rate of [...***...] per each of the full time Scientific Personnel assigned to the R&D Program. The rate set for Scientific Personnel includes the cost of Support Personnel and overhead. It is anticipated that the level of staffing prior to the effective date of the extension shall be between [...***...] full time Scientific Personnel. Furthermore, it is anticipated that the level of staffing after the effective date of the extension (1 January 2002) shall be [...***...] full time Scientific Personnel, although the actual number shall remain under the direction and adjustment of the Steering Committee.
R&D Expenses means Allowable Expenses incurred in connection with research and development of the Product, including, without limitation, manufacture of research and clinical supplies of the Product, determined in accordance with the termns of Section 4.2 of the Collaboration Agreement and with the accounting methodologies set forth in Schedule F to the Collaboration Agreement.
R&D Expenses shall have the meaning set forth in Section 1.4(a).
Examples of R&D Expenses in a sentence
Included in the R&D Expenses line within the accompanying consolidated statement of income.
Expenses: Expenses on Operations 33,511.0670,239.6554,678.4841,889.3628,957.33Employee benefits expenses 775.991,339.881,170.19967.10771.16Finance Costs 205.55446.59354.54230.84152.79Depreciation, amortization and impairment 27.0748.3550.1846.6951.21Other Expenses 225.08429.41423.27308.78234.21CSR and R&D Expenses 101.7476.7461.2359.7546.69 Total Expenses (IV)34,846.4972,580.6256,737.8943,502.5230,213.39 V.
The legal basis for the programme is Article 30(1) of the EIT Law, along with the Implementation Rules for the Enterprise Income Tax Law of the PRC; as well as the following notices: — Notice of the Ministry of Finance, the State Administration of Taxation and the Ministry of Science and Technology on Improving the Policy of Pre-tax Deduction of R&D Expenses.
Figure 11a: R&D Expenses and Generalized Trust Sources: R&D expenses as a percentage of GDP over the period 1980-2010 are taken from the World Bank Development Indicators.
An ECF/ACP: • Is a part of the installation perimeter and a legal line of demarcation and provides the first physical security boundary layer that restricts entry/access to DoD installations.
More Definitions of R&D Expenses
R&D Expenses means the sum of (i) the reasonable out-of-pocket costs incurred by GalaGen in performing its obligations under the Collaboration and [***CONFIDENTIAL TREATMENT REQUESTED; PORTION OMITTED FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION***] per man-hour expended by GalaGen's employees who are performing activities pursuant to the Development Plan.
R&D Expenses shall have the meaning set forth in Section 6.7(b). (108) “Representatives” means, with respect to any Person, any of such Person’s directors, officers, employees, agents, consultants, advisors, accountants, attorneys or other representatives. (109) “Retained Names and Marks” shall have the meaning set forth in Section 6.6. (110) “Reverse Termination Fee” shall have the meaning set forth in Section 8.3(b)(i). (111) “Right of First Negotiation” means the right, but not an obligation, of Buyer to negotiate, before any other Person, a license of the applicable Hydroxy-Compound from Cyclerion. (112) “Second Tranche” means the purchase and sale of the Second Tranche Shares (as defined in the Buyer Parent Purchase Agreement) pursuant to the terms of the Buyer Parent Purchase Agreement. (113) “Securities Act” means the Securities Act of 1933. (114) “Specified Employees” shall have the meaning set forth in Section 6.5(a). (115) “Stockholder Agreements” means the Voting Rights Agreement, Investor Rights Agreement and Right of First Refusal and Co-Sale Agreement of Buyer Parent, in each case in substantially the form set forth on Exhibit C as well as the Cyclerion Stockholder Letter. (116) “Stockholder Approval” shall have the meaning set forth in Section 6.9(a). (117) “Stockholders Meeting” shall have the meaning set forth in Section 6.9(a). (118) “Straddle Period” means any taxable period beginning on or prior to the Closing Date and ending after the Closing Date. (119) “Subsidiary” means with respect to any Person (i) a corporation, fifty percent (50%) or more of the voting or capital stock of which is, as of the time in question, directly or indirectly owned by such Person and (ii) any other Person in which such Person, directly or indirectly, owns fifty percent (50%) or more of the equity or economic interest thereof or has the power to elect or direct the election of fifty percent (50%) or more of the members of the governing body of such Person.
R&D Expenses means the expenses incurred by either Sepracor or Jansxxx xx for their account which are incurred under the R&D Plan (as defined hereafter) and the budget to be agreed between the Parties for such R&D Plan and that are specifically attributable to the development of Rx Products for the United States market. R&D Expenses do not include the Pre-Option Clinical Testing or any other studies not in the R&D Plan agreed between the parties to be conducted prior to exercising the option as defined in Section 2.3(a).
R&D Expenses means research and development expenses of the Partnership including, without limitation, expenses related to the following:
R&D Expenses means the fully-loaded costs, but excluding general corporate overhead, incurred by a Party or for its account, [***] by either Party during the term of the Agreement [***], and ongoing Product support [***] which are consistent with the Development Plan and budget and are specifically attributable to the Product in the Field. "R&D Expenses" shall include the out-of-pocket payments to Third Parties incurred by a Party in carrying out the functions described in the previous sentence.
R&D Expenses shall include the out-of-pocket payments to Third Parties incurred by a Party in carrying out the functions described in the previous sentence.
R&D Expenses means the Direct Costs incurred by [ * ], in the conduct [ * ] of the Agreement[ * ]. “R&D Expenses” shall include the [ * ] incurred by [ * ] in carrying out the functions described in the previous sentence, including [ * ]. Any financial support received from [ * ] shall be [ * ]. In the event that [ * ].